Membrane Lipid Derivatives: Roles of Arachidonic Acid and Its Metabolites in Pancreatic Physiology and Pathophysiology.


Journal

Molecules (Basel, Switzerland)
ISSN: 1420-3049
Titre abrégé: Molecules
Pays: Switzerland
ID NLM: 100964009

Informations de publication

Date de publication:
24 May 2023
Historique:
received: 27 04 2023
revised: 17 05 2023
accepted: 19 05 2023
medline: 12 6 2023
pubmed: 10 6 2023
entrez: 10 6 2023
Statut: epublish

Résumé

One of the most important constituents of the cell membrane is arachidonic acid. Lipids forming part of the cellular membrane can be metabolized in a variety of cellular types of the body by a family of enzymes termed phospholipases: phospholipase A2, phospholipase C and phospholipase D. Phospholipase A2 is considered the most important enzyme type for the release of arachidonic acid. The latter is subsequently subjected to metabolization via different enzymes. Three enzymatic pathways, involving the enzymes cyclooxygenase, lipoxygenase and cytochrome P450, transform the lipid derivative into several bioactive compounds. Arachidonic acid itself plays a role as an intracellular signaling molecule. Additionally, its derivatives play critical roles in cell physiology and, moreover, are involved in the development of disease. Its metabolites comprise, predominantly, prostaglandins, thromboxanes, leukotrienes and hydroxyeicosatetraenoic acids. Their involvement in cellular responses leading to inflammation and/or cancer development is subject to intense study. This manuscript reviews the findings on the involvement of the membrane lipid derivative arachidonic acid and its metabolites in the development of pancreatitis, diabetes and/or pancreatic cancer.

Identifiants

pubmed: 37298790
pii: molecules28114316
doi: 10.3390/molecules28114316
pmc: PMC10254454
pii:
doi:

Substances chimiques

Arachidonic Acid 27YG812J1I
Membrane Lipids 0
Leukotrienes 0
Prostaglandins 0
Phospholipases A2 EC 3.1.1.4

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Government of Extremadura
ID : GR21037

Références

Front Pharmacol. 2020 Aug 19;11:1289
pubmed: 32973519
Dig Dis. 2007;25(3):282-4
pubmed: 17827958
Mol Metab. 2021 Dec;54:101347
pubmed: 34626853
Eur J Gastroenterol Hepatol. 2004 Apr;16(4):383-8
pubmed: 15028970
Cell Calcium. 1994 Mar;15(3):228-40
pubmed: 8194102
Eur J Gastroenterol Hepatol. 2008 Aug;20(8):732-9
pubmed: 18617777
Curr Drug Targets. 2018;19(1):38-54
pubmed: 28124606
Annu Rev Pharmacol Toxicol. 1998;38:97-120
pubmed: 9597150
Cell Calcium. 2012 Feb;51(2):140-8
pubmed: 22197025
Dig Dis Sci. 2020 May;65(5):1376-1384
pubmed: 31598921
Diabetes. 2007 Jan;56(1):197-203
pubmed: 17192482
Diabetes. 2007 Oct;56(10):2616-21
pubmed: 17606874
Ann Intern Med. 1985 Jul;103(1):86-100
pubmed: 3890660
Mol Cell Biochem. 2005 Jan;269(1-2):165-73
pubmed: 15786729
J Cell Physiol. 2018 Nov;233(11):8701-8710
pubmed: 29797580
Anal Biochem. 2010 Dec 15;407(2):233-6
pubmed: 20655865
World J Gastroenterol. 2019 Aug 7;25(29):4019-4042
pubmed: 31413535
Cancer Sci. 2022 Oct;113(10):3579-3592
pubmed: 35848891
Planta Med. 2004 Nov;70(11):1098-100
pubmed: 15549672
Cell Mol Gastroenterol Hepatol. 2015 Jan;1(1):75-86
pubmed: 25729765
Trends Cancer. 2018 Jun;4(6):418-428
pubmed: 29860986
Pancreatology. 2002;2(1):54-60
pubmed: 12120008
Eur J Pharmacol. 2012 Jul 15;687(1-3):28-38
pubmed: 22575522
J Physiol Biochem. 2023 Feb;79(1):235-249
pubmed: 36334253
Am J Pathol. 2002 Aug;161(2):421-8
pubmed: 12163367
Neoplasia. 2007 Nov;9(11):917-26
pubmed: 18030360
Drug Metab Rev. 2013 Aug;45(3):311-52
pubmed: 23865864
Prostaglandins Leukot Essent Fatty Acids. 2006 Mar;74(3):199-213
pubmed: 16412622
Redox Biol. 2015 Dec;6:297-310
pubmed: 26298204
Nutrition. 2019 Oct;66:203-218
pubmed: 31310962
J Physiol Biochem. 2023 Feb;79(1):213-222
pubmed: 36580230
J Biol Chem. 2020 May 15;295(20):6946-6957
pubmed: 32265301
Pancreas. 2009 May;38(4):436-41
pubmed: 19295455
Cancer Metastasis Rev. 2011 Dec;30(3-4):525-40
pubmed: 22009066
Molecules. 2022 Sep 22;27(19):
pubmed: 36234768
Diabete Metab. 1994 Mar-Apr;20(2):146-9
pubmed: 7805951
Mol Cancer. 2003 Jan 07;2:10
pubmed: 12575899
World J Gastrointest Pharmacol Ther. 2010 Feb 6;1(1):3-8
pubmed: 21577288
Proc Natl Acad Sci U S A. 2019 Jun 25;116(26):13026-13035
pubmed: 31182586
Crit Rev Immunol. 2017;37(2-6):127-195
pubmed: 29773019
Biochem Biophys Res Commun. 1999 Aug 11;261(3):726-33
pubmed: 10441493
Acta Physiol (Oxf). 2009 Jan;195(1):13-28
pubmed: 18983441
Am J Physiol Gastrointest Liver Physiol. 2019 Jan 1;316(1):G179-G186
pubmed: 30431318
Cancers (Basel). 2021 Jun 21;13(12):
pubmed: 34205590
Sci Rep. 2016 Jul 06;6:29455
pubmed: 27381829
Pancreas. 2012 May;41(4):518-22
pubmed: 22504378
Pharmacotherapy. 2003 Jan;23(1):9-28
pubmed: 12523457
Pancreatology. 2001;1(4):291-9
pubmed: 12120207
Free Radic Biol Med. 1997;22(6):947-54
pubmed: 9034233
Immunotherapy. 2022 Dec;14(17):1393-1405
pubmed: 36468417
Clin Transl Gastroenterol. 2019 Apr;10(4):e00028
pubmed: 31009406
Cancer Discov. 2021 Aug;11(8):2094-2111
pubmed: 33839689
Toxicol Pathol. 2003 Sep-Oct;31(5):506-13
pubmed: 14692619
Prostaglandins Med. 1981 Dec;7(6):581-9
pubmed: 6798594
Curr Drug Targets Immune Endocr Metabol Disord. 2005 Dec;5(4):439-48
pubmed: 16375696
Lancet. 2015 Jul 4;386(9988):85-96
pubmed: 25616312
Clin Immunol. 2006 Jun;119(3):229-40
pubmed: 16540375
Signal Transduct Target Ther. 2021 Feb 26;6(1):94
pubmed: 33637672
J Cancer Res Clin Oncol. 2002 Oct;128(10):525-32
pubmed: 12384795
J Transl Med. 2022 May 13;20(1):218
pubmed: 35562743
Crit Rev Oncol Hematol. 2018 Jul;127:50-55
pubmed: 29891111
Prostaglandins. 1993 Apr;45(4):315-22
pubmed: 8388115
Prostaglandins Other Lipid Mediat. 2018 May;136:23-32
pubmed: 29605541
Adv Exp Med Biol. 2019;1164:73-87
pubmed: 31576541
Neuro Endocrinol Lett. 2009;30(2):153-79
pubmed: 19675519
Pharmacol Rep. 2007 May-Jun;59(3):247-58
pubmed: 17652824
Biochem Biophys Res Commun. 2018 Mar 25;498(1):79-85
pubmed: 29421656
Mol Endocrinol. 2015 Jun;29(6):791-800
pubmed: 25803446
Int J Mol Sci. 2017 Dec 08;18(12):
pubmed: 29292756
Drugs Today (Barc). 2003 Mar;39(3):203-12
pubmed: 12730704
Biochim Biophys Acta. 2007 Jul;1770(7):1021-7
pubmed: 17434678
Annu Rev Physiol. 1980;42:127-56
pubmed: 6105844
Curr Med Chem. 2019;26(19):3407-3423
pubmed: 28625150
Pancreas. 2002 Jul;25(1):26-30
pubmed: 12131767
Gastro Hep Adv. 2022;1(4):682-697
pubmed: 36277993
Ann Surg Oncol. 2013 Dec;20 Suppl 3:S636-43
pubmed: 23846787
Nat Rev Mol Cell Biol. 2000 Oct;1(1):11-21
pubmed: 11413485
J Adv Res. 2018 Mar 13;11:23-32
pubmed: 30034873
Oxid Med Cell Longev. 2021 Feb 09;2021:8891544
pubmed: 33628394
Hepatogastroenterology. 1999 Sep-Oct;46(29):2731-5
pubmed: 10576338
Antioxidants (Basel). 2021 Apr 08;10(4):
pubmed: 33918063
J Surg Res. 1994 Jan;56(1):37-44
pubmed: 8277767
FASEB J. 2020 Nov;34(11):14850-14862
pubmed: 32918516
Pharmacol Rev. 2004 Sep;56(3):387-437
pubmed: 15317910
Immunology. 2017 Sep;152(1):36-51
pubmed: 28419443
Cancer Metastasis Rev. 2018 Sep;37(2-3):213-225
pubmed: 29971572
J Oncol. 2011;2011:741868
pubmed: 21785593
Mol Cancer Res. 2010 Jun;8(6):821-32
pubmed: 20530583
Prostaglandins Other Lipid Mediat. 2011 Aug;95(1-4):1-10
pubmed: 21757024
Curr Pharm Des. 2004;10(6):577-88
pubmed: 14965321
J Inflamm Res. 2015 Sep 30;8:181-92
pubmed: 26457057
Pharmacol Ther. 2019 Mar;195:100-110
pubmed: 30347209
Nihon Rinsho. 1992 Feb;50(2):349-54
pubmed: 1613989
J Hepatobiliary Pancreat Sci. 2019 Mar;26(3):109-116
pubmed: 30623589
Oncol Lett. 2014 Jun;7(6):1747-1754
pubmed: 24932227
Gut. 2006 Aug;55(8):1165-73
pubmed: 16322109
Cancers (Basel). 2022 Oct 26;14(21):
pubmed: 36358664
Int J Mol Sci. 2022 Oct 03;23(19):
pubmed: 36233022
Cancer Lett. 2018 Apr 28;420:247-258
pubmed: 29408203
Int J Exp Pathol. 2010 Apr;91(2):114-24
pubmed: 20002836
Pharmacol Ther. 2021 Feb;218:107670
pubmed: 32891711
Mol Cancer Res. 2019 Feb;17(2):348-355
pubmed: 30333153
Saudi J Gastroenterol. 2019 Jan-Feb;25(1):3-13
pubmed: 30588953
Cell Mol Biol Lett. 2022 Nov 22;27(1):103
pubmed: 36418969
Cell Signal. 2002 Feb;14(2):153-9
pubmed: 11781140
Clin Exp Pharmacol Physiol. 2010 Oct;37(10):980-8
pubmed: 20626416
Prostaglandins Leukot Essent Fatty Acids. 2005 Aug;73(2):89-97
pubmed: 15964750
PLoS One. 2015 Apr 16;10(4):e0124075
pubmed: 25879541
J Pharmacol Exp Ther. 2010 Aug;334(2):430-8
pubmed: 20439437
Environ Health Perspect. 1990 Mar;84:35-9
pubmed: 2161754
Br J Pharmacol. 2010 Nov;161(5):1002-11
pubmed: 20977452
Int J Biochem Cell Biol. 2015 Dec;69:132-41
pubmed: 26510582
J Lipid Mediat Cell Signal. 1997 Sep;17(1):65-70
pubmed: 9302655
Methods Cell Biol. 2022;168:139-159
pubmed: 35366980
Oncol Rep. 2015 Feb;33(2):661-8
pubmed: 25483364
Biochem Biophys Res Commun. 1983 Jul 29;114(2):743-9
pubmed: 6411091
Biochimie. 2010 Jun;92(6):627-37
pubmed: 20083151
Cancer Lett. 2021 Jan 28;497:165-177
pubmed: 33080311
Basic Clin Pharmacol Toxicol. 2004 Oct;95(4):183-90
pubmed: 15504154
Curr Protoc. 2022 Apr;2(4):e422
pubmed: 35468264
JOP. 2009 May 18;10(3):263-70
pubmed: 19454817
J Adv Pract Oncol. 2013 Jul;4(4):263-8
pubmed: 25032007
Neoplasia. 2008 Aug;10(8):782-96
pubmed: 18670639
Pharmacol Ther. 2022 Jun;234:108049
pubmed: 34848204
Best Pract Res Clin Gastroenterol. 2010 Apr;24(2):143-55
pubmed: 20227028
Cancer Metastasis Rev. 2018 Sep;37(2-3):409-423
pubmed: 30066055
Am J Physiol Gastrointest Liver Physiol. 2014 Jan;306(2):G91-G101
pubmed: 24177032
Anal Bioanal Chem. 2008 Oct;392(4):717-26
pubmed: 18712367
J Clin Invest. 2001 Jul;108(1):25-30
pubmed: 11435452
Front Pharmacol. 2020 May 29;11:819
pubmed: 32547404
Diabetologia. 2017 Jul;60(7):1223-1233
pubmed: 28474159
Biol Chem. 1999 Jul-Aug;380(7-8):903-8
pubmed: 10494840
Curr Cancer Drug Targets. 2004 May;4(3):257-65
pubmed: 15134533
Pancreas. 2013 Apr;42(3):467-74
pubmed: 23090667
World J Gastroenterol. 2014 Aug 21;20(31):10729-39
pubmed: 25152576
Expert Opin Pharmacother. 2003 Dec;4(12):2193-204
pubmed: 14640918
J Clin Invest. 2019 Jun 4;129(9):3594-3609
pubmed: 31162144
Prostaglandins Leukot Essent Fatty Acids. 2000 May;62(5):285-91
pubmed: 10883059
Pancreas. 2011 Jul;40(5):708-14
pubmed: 21602738
J Pathol. 2003 Jul;200(4):429-47
pubmed: 12845611
Curr Drug Metab. 2004 Jun;5(3):211-24
pubmed: 15180491
J Biol Chem. 2001 May 18;276(20):16986-91
pubmed: 11279177
Oncology (Williston Park). 2002 May;16(5 Suppl 4):37-51
pubmed: 12102579
Cells. 2021 Apr 21;10(5):
pubmed: 33919156
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2021 Sept 28;46(9):932-941
pubmed: 34707002
Am J Physiol Gastrointest Liver Physiol. 2007 Dec;293(6):G1196-204
pubmed: 17916652
J Med Chem. 2014 Jan 23;57(2):495-506
pubmed: 24393039
Mini Rev Med Chem. 2007 Jun;7(6):599-608
pubmed: 17584158
FASEB J. 2004 May;18(7):790-804
pubmed: 15117884
Pancreatology. 2003;3(1):26-35
pubmed: 12649561
Carcinogenesis. 1994 Oct;15(10):2107-12
pubmed: 7955040
J Biol Chem. 2002 Jan 4;277(1):141-7
pubmed: 11606585
Int J Mol Sci. 2017 Jan 24;18(2):
pubmed: 28125014
Int J Mol Sci. 2019 Jul 27;20(15):
pubmed: 31357612

Auteurs

Cándido Ortiz-Placín (C)

Instituto de Biomarcadores de Patologías Moleculares, Departamento de Fisiología, Universidad de Extremadura, 10003 Cáceres, Spain.

Alba Castillejo-Rufo (A)

Instituto de Biomarcadores de Patologías Moleculares, Departamento de Fisiología, Universidad de Extremadura, 10003 Cáceres, Spain.

Matías Estarás (M)

Instituto de Biomarcadores de Patologías Moleculares, Departamento de Fisiología, Universidad de Extremadura, 10003 Cáceres, Spain.

Antonio González (A)

Instituto de Biomarcadores de Patologías Moleculares, Departamento de Fisiología, Universidad de Extremadura, 10003 Cáceres, Spain.

Articles similaires

Molecular probes for tracking lipid droplet membrane dynamics.

Lingxiu Kong, Qingjie Bai, Cuicui Li et al.
1.00
Lipid Droplets Molecular Probes Humans Membrane Proteins Animals
Roseobacter Phylogeny RNA, Ribosomal, 16S Seawater Base Composition
Humans Mefloquine Connexins Cryoelectron Microscopy Lipid Bilayers
Microalgae Arachidonic Acid Carbon Biomass High-Throughput Screening Assays

Classifications MeSH